These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32160643)

  • 21. Pharmacological adjuncts to stop bleeding: options and effectiveness.
    Panteli M; Pountos I; Giannoudis PV
    Eur J Trauma Emerg Surg; 2016 Jun; 42(3):303-10. PubMed ID: 26660675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranexamic acid use in severely injured patients, is it always appropriate?
    Duque P; Gonzalez-Zarco L; Martínez R; Gago S; Varela JA
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 May; 68(5):301-303. PubMed ID: 34140128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.
    Hayward CPM; Tasneem S; Rivard GE
    Int J Lab Hematol; 2020 Dec; 42(6):e274-e276. PubMed ID: 33205919
    [No Abstract]   [Full Text] [Related]  

  • 24. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement.
    Ellis MH; Fredman B; Zohar E; Ifrach N; Jedeikin R
    J Clin Anesth; 2001 Nov; 13(7):509-13. PubMed ID: 11704449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranexamic Acid Influences the Immune Response, but not Bacterial Clearance in a Model of Post-Traumatic Brain Injury Pneumonia.
    Draxler DF; Awad MM; Hanafi G; Daglas M; Ho H; Keragala C; Galle A; Roquilly A; Lyras D; Sashindranath M; Medcalf RL
    J Neurotrauma; 2019 Dec; 36(23):3297-3308. PubMed ID: 31140372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic Acid for Acute Hemorrhage: A Narrative Review of Landmark Studies and a Critical Reappraisal of Its Use Over the Last Decade.
    Lier H; Maegele M; Shander A
    Anesth Analg; 2019 Dec; 129(6):1574-1584. PubMed ID: 31743178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranexamic acid for trauma patients: a critical review of the literature.
    Cap AP; Baer DG; Orman JA; Aden J; Ryan K; Blackbourne LH
    J Trauma; 2011 Jul; 71(1 Suppl):S9-14. PubMed ID: 21795884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current place of tranexamic acid in the management of bleeding.
    Hunt BJ
    Anaesthesia; 2015 Jan; 70 Suppl 1():50-3, e18. PubMed ID: 25440395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Coagulation Profile of Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion With and Without Tranexamic Acid.
    Bosch P; Kenkre TS; Soliman D; Londino JA; Novak NE
    Spine Deform; 2019 Nov; 7(6):910-916. PubMed ID: 31732001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tranexamic acid corrects fibrinolysis in the presence of acidemia in a swine model of severe ischemic reperfusion.
    DeBarros M; Hatch Q; Porta CR; Salgar S; Izenberg S; DuBose J; Eckert M; Martin M
    J Trauma Acute Care Surg; 2014 Mar; 76(3):625-32; discussion 632-3. PubMed ID: 24553528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tranexamic acid: a review of its use in surgery and other indications.
    Dunn CJ; Goa KL
    Drugs; 1999 Jun; 57(6):1005-32. PubMed ID: 10400410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifibrinolytic Therapy and Perioperative Considerations.
    Levy JH; Koster A; Quinones QJ; Milling TJ; Key NS
    Anesthesiology; 2018 Mar; 128(3):657-670. PubMed ID: 29200009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
    Moore EE; Moore HB; Gonzalez E; Sauaia A; Banerjee A; Silliman CC
    Transfusion; 2016 Apr; 56 Suppl 2(Suppl 2):S110-4. PubMed ID: 27100746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranexamic acid use during coronary artery bypass grafting.
    Rubens F; Wells P
    Ann Thorac Surg; 1996 Feb; 61(2):774-5. PubMed ID: 8572821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.